SEMA3A and rheumatoid arthritis: Based on the previously reported role of Sema3A and Sema4D, we hypothesized that these immune semaphorins are associated with an imbalance of bone remodeling in RA joints and could be potential biochemical markers of ongoing joint damage in RA patients.